NKTR
Nektar Therapeutics
42.20$
-3.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 90.2% | 83.1% | 80.8% | 86.0% | 93.0% | 86.0% | 89.7% | 89.9% | 93.4% | 95.0% | 77.2% | 67.5% | |
| 14.7% | 8.9% | 12.3% | 4.1% | 9.8% | 14.6% | 15.2% | 20.7% | 13.6% | 5.4% | 17.3% | 3.6% | |
| 84.3% | 76.3% | 73.0% | 79.0% | 79.4% | 84.0% | 85.3% | 84.8% | 89.7% | 87.6% | 74.5% | 62.5% | |
| 0.8% | 0.6% | 1.4% | 0.8% | 0.7% | 0.5% | 0.7% | 0.7% | 0.4% | 0.6% | 0.5% | 0.4% | |
| 3.4% | 4.0% | 4.1% | 4.2% | 0.0% | 0.0% | – | – | – | – | – | – | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 64.0% | 67.1% | 68.0% | 76.8% | 84.1% | 80.0% | 94.6% | 111.7% | 71.8% | 68.0% | 24.5% | 17.5% | |
| 11.8% | 12.9% | 13.2% | 16.7% | 21.9% | 20.2% | 27.7% | 34.4% | 22.0% | 19.1% | 7.6% | 6.5% | |
| 4.3% | 4.8% | 4.9% | 6.2% | 7.0% | 6.5% | 8.5% | 10.6% | 7.4% | 7.3% | 3.0% | 2.1% | |
| 0.7% | 2.5% | 2.2% | 1.9% | 2.8% | 3.8% | 7.0% | 6.9% | 5.2% | 3.8% | 1.3% | 2.3% | |
| 36.0% | 32.9% | 32.0% | 23.2% | 15.9% | 20.0% | 5.4% | -11.7% | 28.2% | 32.0% | 75.5% | 82.5% | |
| -776.8% | -873.6% | -887.4% | -1,038.8% | -1,170.1% | -1,183.5% | -1,423.3% | -1,777.4% | -1,235.9% | -1,341.0% | -498.5% | -351.2% | |
| 2.9% | 3.2% | 3.3% | 4.1% | 4.5% | 4.7% | 5.5% | 6.8% | 4.7% | 7.2% | 3.2% | 3.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.